BridgeBio Pharma (BBIO) EBITDA Margin (2020 - 2026)
BridgeBio Pharma's EBITDA Margin was -2.45% in Q3 2026, up 115.48 percentage points from -117.93% a year earlier and up 40.27 percentage points from the prior quarter.
Powered by 
Analysis
BridgeBio Pharma (BBIO) EBITDA Margin (2020 - 2026) Analysis & Trends
On a trailing twelve-month basis, BridgeBio Pharma's EBITDA Margin was -37.27% through Sep 30, 2026, up 131.75 percentage points year-over-year; for FY2025, it came in at -101.98%, up 159.14 percentage points from FY2024.
- EBITDA Margin shows a five-year change of +5632.36 percentage points (FY2020 to FY2025).
- In earlier years, EBITDA Margin was -261.12% in FY2024 (+6102.08 pp), -6363.21% in FY2023 (-5712.28 pp), -650.93% in FY2022 (+167.81 pp) and -818.73% in FY2021 (+4915.61 pp).
- The Q3 2026 figure marks the highest quarterly EBITDA Margin since Q1 2024.
- Compared with a year earlier, EBITDA Margin has increased for six straight quarters, with an average year-over-year change of +3109.40 percentage points over the last eight quarters.
- The best year-over-year quarter for EBITDA Margin over five years was Q4 2021 (a gain of 102869.24 percentage points); the worst was Q3 2022 (a drop of 31346.68 percentage points).
- Per Business Quant data, BBIO's EBITDA Margin in the three quarters before Q3 2026 was -42.72% (Q2 2026), -52.93% (Q1 2026) and -88.65% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 36.69% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 32.68% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 46.88% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 40.60% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 39.77% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 46.62% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 50.63% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 42.49% |
| 10 | BridgeBio Pharma | 15.42 Bn | 11.64 Bn | 332.72 Mn | -2.45% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -2.45% |
| Jun 30, 2026 | -42.72% |
| Mar 31, 2026 | -52.93% |
| Dec 31, 2025 | -88.65% |
| Sep 30, 2025 | -117.93% |
| Jun 30, 2025 | -118.96% |
| Mar 31, 2025 | -87.00% |
| Dec 31, 2024 | -3,784.34% |
| Sep 30, 2024 | -6,962.37% |
| Jun 30, 2024 | -8,024.22% |
| Mar 31, 2024 | 0.92% |
| Dec 31, 2023 | -10,076.28% |
| Sep 30, 2023 | -3,814.54% |
| Jun 30, 2023 | -8,803.29% |
| Mar 31, 2023 | -6,819.82% |
| Dec 31, 2022 | -6,822.03% |
| Sep 30, 2022 | -37,713.31% |
| Jun 30, 2022 | -106.57% |
| Mar 31, 2022 | -10,141.32% |
| Dec 31, 2021 | -1,273.38% |
API Access
BridgeBio Pharma EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=BBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "BBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=BBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();